The installation of surgical robots in China is projected to rise significantly, with 97 units expected in 2025 and 136 in 2026, marking a 40% increase. The market size is anticipated to grow from 3.9 billion to 4.4 billion. Notably, domestic systems have surpassed 41% of new installations, with prices 30-40% lower than imported models.
The Healthcare Bureau convened seven manufacturers and five hospitals, emphasizing the need to avoid using surgical robots merely for show and to prevent unnecessary surgeries that could inflate costs. The core issues surrounding surgical robots are not related to pricing or insurance reimbursements, which have been addressed through new payment structures and classifications for robotic-assisted surgeries.
Looking ahead, the focus should be on establishing a regular cross-brand training mechanism for surgeons, as current training is heavily influenced by the brand of the robot used. The industry must also consider the implications of the BMJ article highlighting the need for structured training paths to ensure safety and effectiveness in robotic surgeries, as the performance of these expensive tools heavily relies on the skill of the operating physician.
Editor's Note
The surgical robotics market in China is evolving rapidly, with significant growth in installations and market size. However, the emphasis on training and operational standards remains critical to ensure patient safety and effective use of these technologies. The recent initiatives by the Healthcare Bureau to regulate and standardize practices reflect a growing awareness of the challenges in this sector, particularly regarding the need for structured training and accountability in robotic surgeries.
Leave a comment